Purchase Order N6809622P0004
Award Date
10/21/21
Potential Completion Date
9/27/22
Potential Value
$81K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Bureau of Medicine and Surgery
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Agana Heights, Guam
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a firm-fixed-price purchase order to Immucor Inc., a for-profit manufacturer of goods, for the delivery of blood typing reagents. The $228,353.45 contract has an ultimate completion date of September 30, 2027. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood banking supplies to federal agencies such as the Department of Veterans Affairs and the Indian Health Service. This award is not set aside and is...
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
This is a firm fixed-price delivery order contract awarded by the Air Education and Training Command, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract is for the provision of blood typing reagents, with a ceiling value of $121,323.95 and a completion date of September 30, 2020. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare agencies, including the Department of Veterans...
This federal contract award to Immucor Inc., a for-profit manufacturer, is for the provision of reagents and an echo analyzer to support blood bank operations. The $784,855.51 firm fixed price purchase order was awarded on October 1, 2016 by the Medical Command division of the Department of Defense, with a period of performance through September 30, 2019. No set-aside designation was used. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...
This is a delivery order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Immucor Inc. for the annual supply of blood testing reagents. The award, which has a ceiling value of $130,059.42, is made under Immucor's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. As a firm fixed-price contract, this delivery order does not utilize any set-aside designations. Immucor is a leading provider of automated...
This is a $61,238.20 firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Immucor Inc. for the delivery of blood bank reagents. The contract has an ultimate completion date of October 1, 2027. Immucor, a manufacturer of in vitro diagnostic products for transfusion and transplantation testing, was awarded this sole source contract under FAR 13.106-1 based on its specialized capabilities and proprietary solutions. The contract is not associated with a federal...
This is a firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract is for a base year plus four option years, with a ceiling value of $29,848.00, for the provision of blood bank reagents. The contract is issued under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, and does not have a set-aside designation. Immucor is a key supplier of...
This is a federal contract awarded by the Defense Health Agency to Immucor Inc., a for-profit organization and manufacturer of goods. The contract is for the delivery of reagents under the Invitro Diagnostics, Reagents, Test Federal Supply Schedule (FSS-65-VII). The contract has a firm fixed price of $107,634.54 and a completion date of September 30, 2023. Immucor Inc. has a history of providing specialized reagents, blood analyzers, testing equipment, and related consumables to support blood...